Skip to content
Brand AI

Recordati

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2020

    FDA approves Isturisa for Cushing’s disease

    The FDA approved Recordati’s Isturisa, an oral drug for adults with Cushing’s disease who cannot be treated with surgery or for whom surgery is ineffective.

    Source